Role of microRNAs in Venous Thromboembolism
Open Access
- 9 April 2020
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 21 (7) , 2602
Abstract
MicroRNAs (miRNAs) are non-coding RNAs that execute their function by targeted downregulation of gene expressions. There is growing evidence from epidemiological studies and animal models suggesting that the expression level of miRNAs is dysregulated in venous thromboembolism (VTE). In this review, we summarize the current knowledge on the role of miRNAs as biomarkers for VTE and provide general insight into research exploring the modulation of miRNA activity in animal models of venous thrombosis. Up to now, published studies have yielded inconsistent results on the role of miRNAs as biomarkers for VTE with most of the reports focused on diagnostic research. The limited statistical power of the individual studies, due to the small sample sizes, may substantially contribute to the poor reproducibility among studies. In animal models, over-expression or inhibition of some miRNAs appear to influence venous thrombus formation and resolution. However, there is an important gap in knowledge on the potential role of miRNAs as therapeutic targets in VTE. Future research involving large cohorts should be designed to clarify the clinical usefulness of miRNAs as biomarkers for VTE, and animal model studies should be pursued to unravel the role of miRNAs in the pathogenesis of VTE and their potential as therapeutic targets.Keywords
This publication has 72 references indexed in Scilit:
- Cell-free microRNAs: potential biomarkers in need of standardized reportingFrontiers in Genetics, 2013
- Critical Review of Mouse Models of Venous ThrombosisArteriosclerosis, Thrombosis, and Vascular Biology, 2012
- The miR-143/-145 cluster regulates plasminogen activator inhibitor-1 in bladder cancerBritish Journal of Cancer, 2011
- MicroRNA-134 as a potential plasma biomarker for the diagnosis of acute pulmonary embolismJournal of Translational Medicine, 2011
- MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteinsNature Cell Biology, 2011
- Involvement of miR-30c and miR-301a in immediate induction of plasminogen activator inhibitor-1 by placental growth factor in human pulmonary endothelial cellsBiochemical Journal, 2011
- MicroRNAs: Target Recognition and Regulatory FunctionsCell, 2009
- Serum MicroRNAs Are Promising Novel BiomarkersPLOS ONE, 2008
- Circulating microRNAs as stable blood-based markers for cancer detectionProceedings of the National Academy of Sciences, 2008
- Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cellsNature Cell Biology, 2007